TrialInvestigational new drugs2014

Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.

Neelesh Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.